Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
Clinical Transplantation
|
December 13, 2019
Donor acute kidney injury and its effect on 1-year post-transplant kidney allograft fibrosis
Dirk J van der Windt, Rajil Mehta, Dana R Jorgensen, et al.
The Journal of Heart Transplantation
|
May 1, 1986
Use of the mini Jarvik-7 total artificial heart as a bridge to transplantation
L D Joyce, M R Pritzker, J C Kiser, et al.
The Annals of Thoracic Surgery
|
January 1, 1991
Mechanical circulatory assistance after heart transplantation
R W Emery, F Eales, L D Joyce, et al.
Organic & Biomolecular Chemistry
|
December 16, 2010
Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD
Yushma Bhurruth-Alcor, Therese Røst, Michael R Jorgensen, et al.
Transplantation Direct
|
June 14, 2021
Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
Itunu Owoyemi, Srijan Tandukar, Dana R Jorgensen, et al.
Pain
|
May 14, 2011
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Rikke Rie Hansen, Christian K Nielsen, Arafat Nasser, et al.
Nature Communications
|
September 27, 2024
Scar matrix drives Piezo1 mediated stromal inflammation leading to placenta accreta spectrum
Du Wenqiang, Ashkan Novin, Yamin Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 9, 2009
DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA
Mathieu Mével, Nazila Kamaly, Sergio Carmona, et al.
Cancer Research
|
December 28, 2014
Accelerated tumor progression in mice lacking the ATP receptor P2X7
Elena Adinolfi, Marina Capece, Alessia Franceschini, et al.
Alimentary Pharmacology & Therapeutics
|
October 1, 2011
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
M H Imam, E Sinakos, A A Gossard, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
Clinical Transplantation
|
December 13, 2019
Donor acute kidney injury and its effect on 1-year post-transplant kidney allograft fibrosis
Dirk J van der Windt, Rajil Mehta, Dana R Jorgensen, et al.
The Journal of Heart Transplantation
|
May 1, 1986
Use of the mini Jarvik-7 total artificial heart as a bridge to transplantation
L D Joyce, M R Pritzker, J C Kiser, et al.
The Annals of Thoracic Surgery
|
January 1, 1991
Mechanical circulatory assistance after heart transplantation
R W Emery, F Eales, L D Joyce, et al.
Organic & Biomolecular Chemistry
|
December 16, 2010
Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD
Yushma Bhurruth-Alcor, Therese Røst, Michael R Jorgensen, et al.
Transplantation Direct
|
June 14, 2021
Impact of Subclinical and Clinical Kidney Allograft Rejection Within 1 Year Posttransplantation Among Compatible Transplant With Steroid Withdrawal Protocol
Itunu Owoyemi, Srijan Tandukar, Dana R Jorgensen, et al.
Pain
|
May 14, 2011
P2X7 receptor-deficient mice are susceptible to bone cancer pain
Rikke Rie Hansen, Christian K Nielsen, Arafat Nasser, et al.
Nature Communications
|
September 27, 2024
Scar matrix drives Piezo1 mediated stromal inflammation leading to placenta accreta spectrum
Du Wenqiang, Ashkan Novin, Yamin Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 9, 2009
DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA
Mathieu Mével, Nazila Kamaly, Sergio Carmona, et al.
Cancer Research
|
December 28, 2014
Accelerated tumor progression in mice lacking the ATP receptor P2X7
Elena Adinolfi, Marina Capece, Alessia Franceschini, et al.
Alimentary Pharmacology & Therapeutics
|
October 1, 2011
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
M H Imam, E Sinakos, A A Gossard, et al.
Page
of 17